Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins

The latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus functions as an origin-binding protein (OBP) and transcriptional regulator. LANA binds the terminal repeats via the C-terminal DNA-binding domain (DBD) to support latent DNA replication. To date, the structure of LANA has not been solved. Sequence alignments among OBPs of gammaherpesviruses have revealed that the C terminus of LANA is structurally related to EBNA1, the OBP of Epstein–Barr virus. Based on secondary structure predictions for LANADBD and published structures of EBNA1DBD, this study used bioinformatics tools to model a putative structure for LANADBD bound to DNA. To validate the predicted model, 38 mutants targeting the most conserved motifs, namely three α-helices and a conserved proline loop, were constructed and functionally tested. In agreement with data for EBNA1, residues in helices 1 and 2 mainly contributed to sequence-specific DNA binding and replication activity, whilst mutations in helix 3 affected replication activity and multimer formation. Additionally, several mutants were isolated with discordant phenotypes, which may aid further studies into LANA function. In summary, these data suggest that the secondary and tertiary structures of LANA and EBNA1 DBDs are conserved and are critical for (i) sequence-specific DNA binding, (ii) multimer formation, (iii) LANA-dependent transcriptional repression, and (iv) DNA replication.

• Publication year

  2010

• Venue

  Journal of General Virology

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/vir.0.020958-0PMID 20484563PMCID 3066550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein secondary structure prediction.

  2010cited by this paper
• Conserved domains and structure prediction of human cytomegalovirus UL27 protein

  2008cited by this paper
• Mutational Evidence for a Structural Model of the Lassa Virus RNA Polymerase Domain and Identification of Two Residues, Gly1394 and Asp1395, That Are Critical for Transcription but Not Replication of the Genome

  2008cited by this paper
• The papillomavirus E2 DNA binding domain.

  2008cited by this paper
• ZRANK: Reranking protein docking predictions with an optimized energy function

  2007cited by this paper
• Human Herpesviruses: Gammaherpesvirus maintenance and replication during latency

  2007cited by this paper
• Determination of Kaposi's Sarcoma-Associated Herpesvirus C-Terminal Latency-Associated Nuclear Antigen Residues Mediating Chromosome Association and DNA Binding

  2007influential reference
• Structure and function of latency-associated nuclear antigen.

  2007cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes

  2006cited by this paper
• RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells.

  2006cited by this paper
• Latency-Associated Nuclear Antigen (LANA) of Kaposi's Sarcoma-Associated Herpesvirus Interacts with Origin Recognition Complexes at the LANA Binding Sequence within the Terminal Repeats

  2006cited by this paper
• The Nucleosomal Surface as a Docking Station for Kaposi's Sarcoma Herpesvirus LANA

  2006cited by this paper
• M-ZDOCK: a grid-based approach for Cn symmetric multimer docking

  2005cited by this paper
• Sequence–structure–function relationships of a tRNA (m7G46) methyltransferase studied by homology modeling and site‐directed mutagenesis

  2005cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces a Strong Bend on Binding to Terminal Repeat DNA

  2005cited by this paper
• A simple physical model for the prediction and design of protein-DNA interactions.

  2004cited by this paper
• ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin

  2004cited by this paper
• ModLoop: automated modeling of loops in protein structures

  2003cited by this paper
• The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Permits Replication of Terminal Repeat-Containing Plasmids

  2003cited by this paper
• The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Supports Latent DNA Replication in Dividing Cells

  2002cited by this paper
• Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication*

  2002cited by this paper
• Functional Dissection of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Involved in Latent DNA Replication and Transcription of Terminal Repeats of the Viral Genome

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Amino Acid Substitution Analyses of the DNA Contact Region, Two Amphipathic α-Helices and a Recognition-Helix-Like Helix outside the Dimeric β-Barrel of Epstein-Barr Virus Nuclear Antigen 1

  2001cited by this paper
• Enhancement of protein modeling by human intervention in applying the automatic programs 3D‐JIGSAW and 3D‐PSSM

  2001cited by this paper
• Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus

  2001cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA

  2001cited by this paper
• DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus

  2001cited by this paper
• Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein–Barr virus

  2001cited by this paper
• Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies

  2000cited by this paper
• T-Coffee: A novel method for fast and accurate multiple sequence alignment.

  2000cited by this paper
• Functional Analyses of the EBNA1 Origin DNA Binding Protein of Epstein-Barr Virus

  2000cited by this paper
• Two Domains of the Epstein-Barr Virus Origin DNA-binding Protein, EBNA1, Orchestrate Sequence-specific DNA Binding*

  2000cited by this paper
• The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

  1999cited by this paper
• Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

  1999cited by this paper
• Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions.

  1996cited by this paper
• EBNA1 and E2: a new paradigm for origin-binding proteins?

  1996cited by this paper
• Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences.

  1996cited by this paper
• The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission

  1996cited by this paper
• KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

  1996cited by this paper
• Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA.

  1996cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

  1995cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

  1995cited by this paper
• Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DMA-binding domain bound to its DNA target

  1992cited by this paper
• New mammalian expression vectors

  1990cited by this paper
• Product review. New mammalian expression vectors.

  1990cited by this paper
• Selective extraction of polyoma DNA from infected mouse cell cultures.

  1967cited by this paper
• Virology

  1955cited by this paper

• Kaposi’s Sarcoma Herpesvirus Genome Persistence Please share how this access benefits you. Your story matters

  2016cites this paper
• Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design

  2016cites this paper
• Kaposi’s Sarcoma Herpesvirus Genome Persistence

  2016cites this paper
• KSHV Genome Replication and Maintenance

  2016cites this paper
• Next-Generation Sequencing in the Understanding of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Biology

  2016cites this paper
• The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA

  2015influential citation
• Crystallization, room-temperature X-ray diffraction and preliminary analysis of Kaposi's sarcoma herpesvirus LANA bound to DNA.

  2014cites this paper
• Small and large-scale gene regulation in Kaposi's Sarcoma-associated Herpesvirus

  2013cites this paper
• A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins

  2013cites this paper
• Crystal Structure of the Gamma-2 Herpesvirus LANA DNA Binding Domain Identifies Charged Surface Residues Which Impact Viral Latency

  2013cites this paper
• Viral genome maintenance and latent replication of human gammaherpesviruses

  2013cites this paper
• Molecular Basis for Oligomeric-DNA Binding and Episome Maintenance by KSHV LANA

  2013cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency

  2012cites this paper
• A Protein Array Screen for Kaposi's Sarcoma-Associated Herpesvirus LANA Interactors Links LANA to TIP60, PP2A Activity, and Telomere Shortening

  2012cites this paper
• Phosphorylation of the Chromatin Binding Domain of KSHV LANA

  2012cites this paper
• Kaposi’s Sarcoma-Associated Virus Governs Gene Expression Profiles Toward B Cell Transformation

  2012cites this paper
• Identification of Host-Chromosome Binding Sites and Candidate Gene Targets for Kaposi's Sarcoma-Associated Herpesvirus LANA

  2012cites this paper
• Unbiased Mutagenesis of MHV68 LANA Reveals a DNA-Binding Domain Required for LANA Function In Vitro and In Vivo

  2012cites this paper
• Protein Arginine Methyltransferase 1-directed Methylation of Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen*

  2011cites this paper
• An Empirical Strategy for Characterizing Bacterial Proteomes across Species in the Absence of Genomic Sequences

  2010cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2009cites this paper
• Unbiased Mutagenesis of MHV 68 LANA Reveals a DNA-Binding Domain Required for LANA Function In Vitro and In Vivo

  year unknowncites this paper